Botanical species · safety record
Caulophyllum thalictroides
The EFSA Compendium of Botanicals holds 33 constituent measurements and 1 adverse-effect record for Caulophyllum thalictroides. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.
Accepted name in source: Caulophyllum thalictroides (L.) Michx.
Also recorded as
Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.
Regulatory presence
Health Canada's Licensed Natural Health Products Database holds 88 licensed products naming Caulophyllum thalictroides as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.
Extract types on licence
Source material stated
What the records describe
Constituents measured
- N-methylcytisine7
- Baptifoline5
- Magnoflorine4
- Quinolizidine alkaloids3
- Thermopsine3
- Alkaloids2
- Anagyrine2
- Triterpene saponins2
- (-)-sparteine1
- Isolupanine1
Plant parts
- Roots and other underground parts30
- Live plants3
- Unspecified1
Preparations
- Solvent extraction30
- Drying (dehydration)3
Effect types
- Systemic1
Target tissues
- Digestive1
Recorded constituents
What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.
| Substance | Plant part | Preparation | Concentration | Analytical method | Source |
|---|---|---|---|---|---|
| (-)-sparteine | Roots and other underground parts | Solvent extraction | — | GC-MS | Resolve DOI |
| Alkaloids | Roots and other underground parts | Solvent extraction | — | High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC) | Resolve DOI |
| Alkaloids | Roots and other underground parts | Solvent extraction | — | Nuclear Magnetic Resonance (NMR) | Resolve DOI |
| Anagyrine | Roots and other underground parts | Solvent extraction | ≥ 0.18 Milligram/gram | High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC) | Resolve DOI |
| Anagyrine | Roots and other underground parts | Solvent extraction | ≤ 0.19 Milligram/gram | High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC) | Resolve DOI |
| Baptifoline | Roots and other underground parts | Solvent extraction | ≤ 1600 Milligram/kilogram | GC-MS | Resolve DOI |
| Baptifoline | Roots and other underground parts | Solvent extraction | — | GC-MS | Resolve DOI |
| Baptifoline | Roots and other underground parts | Solvent extraction | ≥ 0.71 Milligram/gram | High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC) | Resolve DOI |
| Baptifoline | Roots and other underground parts | Solvent extraction | ≥ 9 Milligram/kilogram | GC-MS | Resolve DOI |
| Baptifoline | Roots and other underground parts | Solvent extraction | ≤ 0.75 Milligram/gram | High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC) | Resolve DOI |
| Isolupanine | Roots and other underground parts | Solvent extraction | — | GC-MS | Resolve DOI |
| Lupanine | Roots and other underground parts | Solvent extraction | — | GC-MS | Resolve DOI |
| Magnoflorine | Roots and other underground parts | Solvent extraction | ≥ 11 Milligram/gram | High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC) | Resolve DOI |
| Magnoflorine | Roots and other underground parts | Solvent extraction | ≤ 11.08 Milligram/gram | High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC) | Resolve DOI |
| Magnoflorine | Roots and other underground parts | Solvent extraction | — | GC-MS | Resolve DOI |
| Magnoflorine | Roots and other underground parts | Solvent extraction | — | GC-MS | Resolve DOI |
| N-methylcytisine | Roots and other underground parts | Solvent extraction | ≥ 0.9 Milligram/gram | High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC) | Resolve DOI |
| N-methylcytisine | Roots and other underground parts | Solvent extraction | ≤ 0.91 Milligram/gram | High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC) | Resolve DOI |
| N-methylcytisine | Roots and other underground parts | Solvent extraction | ≥ 5 Milligram/kilogram | GC-MS | Resolve DOI |
| N-methylcytisine | Live plants | Drying (dehydration) | ≤ 0.04 Percent | — | Resolve DOI |
| N-methylcytisine | Roots and other underground parts | Solvent extraction | ≤ 850 Milligram/kilogram | GC-MS | Resolve DOI |
| N-methylcytisine | Roots and other underground parts | Solvent extraction | — | GC-MS | Resolve DOI |
| N-methylcytisine | Live plants | Drying (dehydration) | ≥ 0.003 Percent | — | Resolve DOI |
| Quinolizidine alkaloids | Roots and other underground parts | Solvent extraction | — | GC-MS | Resolve DOI |
| Quinolizidine alkaloids | Roots and other underground parts | Solvent extraction | ≤ 2840 Milligram/kilogram | GC-MS | Resolve DOI |
| Quinolizidine alkaloids | Roots and other underground parts | Solvent extraction | ≥ 16 Milligram/kilogram | GC-MS | Resolve DOI |
| Saponin glycosides | Live plants | Drying (dehydration) | — | — | Resolve DOI |
| Taspine | Roots and other underground parts | Solvent extraction | — | GC-MS | Resolve DOI |
| Thermopsine | Roots and other underground parts | Solvent extraction | ≤ 390 Milligram/kilogram | GC-MS | Resolve DOI |
| Thermopsine | Roots and other underground parts | Solvent extraction | ≥ 2 Milligram/kilogram | GC-MS | Resolve DOI |
| Thermopsine | Roots and other underground parts | Solvent extraction | — | GC-MS | Resolve DOI |
| Triterpene saponins | Roots and other underground parts | Solvent extraction | — | Nuclear Magnetic Resonance (NMR) | Resolve DOI |
| Triterpene saponins | Roots and other underground parts | Solvent extraction | — | High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC) | Resolve DOI |
Recorded adverse effects
Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.
| Effect | Target tissue | Plant part | Preparation | Test organism | Test type | Source |
|---|---|---|---|---|---|---|
| Systemic | Digestive | Unspecified | — | Human (as organism) | Case report | No resolvable identifier |
Cited sources
The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.
- Betz, JM., Andrzejewski, D., Troy, A., Casey, RE., Obermeyer, WR., Page, SW., Woldemariam, TZ. Gas chromatographic determination of toxic quinolizidine alkaloids in blue cohosh Caulophyllum thalictroides (L,) Michx . Phytochemical analysis, 1998, vol. 9, no. 5, p. 232-236. DOI
- Kennelly, EJ., Flynn, TJ., Mazzola, EP., Roach, JA., McCloud, TG., Danford, DE., Betz, JM. Detecting potential teratogenic alkaloids from blue cohosh rhizomes using an in vitro rat embryo culture . Journal of natural products, 1999, vol. 62, no. 10, p. 1385-1389. DOI
- Woldemariam, TZ., Betz, JM., Houghton, PJ. Analysis of aporphine and quinolizidine alkaloids from Caulophyllum thalictroides by densitometry and HPLC . Journal of pharmaceutical and biomedical analysis, 1997, vol. 15, no. 6, p. 839-843. DOI
- Rao, RB., Hoffman, RS. Nicotinic toxicity from tincture of blue cohosh (Caulophyllum thalictroides) used as an abortifacient . Veterinary and human toxicology, 2002, vol. 44, no. 4, p. 221-222.
- Ganzera, M., Dharmaratne, HRW., Nanayakkara, NPD., Khan, IA. Determination of saponins and alkaloids in Caulophyllum thalictroides (blue cohosh) by high-performance liquid chromatography and evaporative light scattering detection . Phytochemical analysis, 2003, vol. 14, no. 1, p. 1-7. DOI
- Ali, Zulfiqar., Khan, Ikhlas A. Alkaloids and saponins from blue cohosh. Phytochemistry, 2008, vol. 69, no. 4, p. 1037-1042. DOI
- Schep, Leo J., Slaughter, Robin J., Beasley, D. Michael G. Nicotinic plant poisoning. Clinical toxicology, 2009, vol. 47, no. 8, p. 771-781. DOI
Boundary
A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.
Continue
Europe PMC
Every record indexed for this species, resolvable and re-runnable.
All speciesSubstance index
Search and browse every species this world holds under source and hash.
Before anything elseSafety Centre
Interactions, contraindications and the escalation boundary this world does not cross.
In its own termsTraditions
How the living traditions approach preparation, use and context.